Literature DB >> 6860706

Properties and distribution of phosphatidylinositol-specific phospholipase C in human and horse platelets.

W Siess, E G Lapetina.   

Abstract

Phospholipase C has been studied in homogenates, total particulate and soluble fractions of horse and human platelets. This enzyme, assayed with exogenous L-3-phosphatidyl[14C]inositol, is predominantly localized in the soluble fraction and its distribution parallels that of lactate dehydrogenase. A small percentage of activity present in the particulate fraction seems to be due to contamination with soluble enzyme. Enzyme from horse and human platelets appears identical, having a Km of 0.10-0.15 mM, acid pH optimum (pH 5.5) and showing Ca2+-dependency and weak inhibition by deoxycholate. Analysis of the reaction products shows the formation of myo-inositol 1,2-cyclic phosphate and myo-inositol 1-phosphate in almost equal amounts. Platelet stimulation with thrombin does not seem to induce association of the cytosolic activity to the membranes. The cytosolic activity is not affected by pretreatment of the intact platelets with prostacyclin or thrombin. Degradation of phosphatidylinositol present in a membrane fraction isolated from platelets by cytosolic phospholipase C requires addition of deoxycholate. Our information suggests that the degradation of phosphatidylinositol in stimulated platelets is mainly achieved by exposure of the substrate to the cytosolic enzyme and by an increase of the free Ca2+ concentration needed for optimal phospholipase C activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6860706     DOI: 10.1016/0005-2760(83)90131-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets.

Authors:  D L Nunn; S P Watson
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

2.  Characterization of partially purified phospholipase C from human platelet membranes.

Authors:  Y Banno; Y Nozawa
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

3.  Characterization of phosphoinositide-specific phospholipase C from human platelets.

Authors:  V Manne; H F Kung
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

4.  Activation of phospholipase C associated with isolated rabbit platelet membranes by guanosine 5'-[gamma-thio]triphosphate and by thrombin in the presence of GTP.

Authors:  J K Hrbolich; M Culty; R J Haslam
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

5.  Effects of arachidonic acid on the gap junctions of neonatal rat heart cells.

Authors:  G S Fluri; A Rüdisüli; M Willi; S Rohr; R Weingart
Journal:  Pflugers Arch       Date:  1990-10       Impact factor: 3.657

6.  Ionophore A23187 induces a refractory state in thrombin-activated release of inositol phosphates.

Authors:  G Moscat; F Moreno; S Iglesias; P Garcia-Barreno; A M Municio
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

7.  Phospholipase A2 and phospholipase C are activated by distinct GTP-binding proteins in response to alpha 1-adrenergic stimulation in FRTL5 thyroid cells.

Authors:  R M Burch; A Luini; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

8.  Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor.

Authors:  J M Ritter
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

9.  The role of the phosphatidylinositol turnover in 12-hydroxyeicosatetraenoic acid generation from human platelets by Escherichia coli alpha-haemolysin, thrombin and fluoride.

Authors:  B König; W König
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

10.  pH-dependent stimulation by Ca2+ of prostacyclin synthesis in rat aortic rings: effects of drugs and inorganic ions.

Authors:  J M Ritter; C E Frazer; G W Taylor
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.